
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Clinipace Worldwide-a global full-service clinical research organization (CRO)-announced the launch of a new regulatory and strategic development consultancy called RSD Global Consulting (RSDGC). The consultancy provides strategic and regulatory support in the U.S., Europe, and Asia Pacific.
Read the full release






